全文获取类型
| 收费全文 | 170980篇 |
| 免费 | 33300篇 |
| 国内免费 | 2540篇 |
专业分类
| 耳鼻咽喉 | 5386篇 |
| 儿科学 | 5942篇 |
| 妇产科学 | 2816篇 |
| 基础医学 | 5722篇 |
| 口腔科学 | 2176篇 |
| 临床医学 | 28118篇 |
| 内科学 | 53001篇 |
| 皮肤病学 | 7694篇 |
| 神经病学 | 16625篇 |
| 特种医学 | 7219篇 |
| 外科学 | 44398篇 |
| 综合类 | 318篇 |
| 现状与发展 | 72篇 |
| 一般理论 | 10篇 |
| 预防医学 | 8096篇 |
| 眼科学 | 3582篇 |
| 药学 | 2199篇 |
| 中国医学 | 63篇 |
| 肿瘤学 | 13383篇 |
出版年
| 2024年 | 699篇 |
| 2023年 | 4941篇 |
| 2022年 | 1593篇 |
| 2021年 | 3828篇 |
| 2020年 | 6398篇 |
| 2019年 | 2739篇 |
| 2018年 | 8137篇 |
| 2017年 | 7798篇 |
| 2016年 | 8937篇 |
| 2015年 | 9032篇 |
| 2014年 | 16337篇 |
| 2013年 | 16636篇 |
| 2012年 | 7237篇 |
| 2011年 | 7174篇 |
| 2010年 | 11333篇 |
| 2009年 | 15046篇 |
| 2008年 | 7225篇 |
| 2007年 | 5445篇 |
| 2006年 | 7858篇 |
| 2005年 | 5038篇 |
| 2004年 | 4138篇 |
| 2003年 | 3014篇 |
| 2002年 | 3085篇 |
| 2001年 | 3908篇 |
| 2000年 | 3091篇 |
| 1999年 | 3324篇 |
| 1998年 | 3797篇 |
| 1997年 | 3591篇 |
| 1996年 | 3483篇 |
| 1995年 | 3338篇 |
| 1994年 | 2040篇 |
| 1993年 | 1660篇 |
| 1992年 | 1427篇 |
| 1991年 | 1449篇 |
| 1990年 | 1129篇 |
| 1989年 | 1227篇 |
| 1988年 | 1063篇 |
| 1987年 | 880篇 |
| 1986年 | 937篇 |
| 1985年 | 749篇 |
| 1984年 | 599篇 |
| 1983年 | 566篇 |
| 1982年 | 567篇 |
| 1981年 | 439篇 |
| 1980年 | 401篇 |
| 1979年 | 332篇 |
| 1978年 | 362篇 |
| 1977年 | 418篇 |
| 1975年 | 298篇 |
| 1972年 | 323篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
91.
Giorgio Gandaglia Guillaume Ploussard Massimo Valerio Agostino Mattei Cristian Fiori Nicola Fossati Armando Stabile Jean-Baptiste Beauval Bernard Malavaud Mathieu Roumiguié Daniele Robesti Paolo Dell’Oglio Marco Moschini Stefania Zamboni Arnas Rakauskas Francesco De Cobelli Francesco Porpiglia Francesco Montorsi Alberto Briganti 《European urology》2019,75(3):506-514
Background
Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men diagnosed via magnetic resonance imaging (MRI)-targeted biopsies.Objective
To assess the accuracy of available tools to predict LNI and to develop a novel model for men diagnosed via MRI-targeted biopsies.Design, setting, and participants
A total of 497 patients diagnosed via MRI-targeted biopsies and treated with RP and extended pelvic lymph node dissection (ePLND) at five institutions were retrospectively identified.Outcome measurements and statistical analyses
Three available models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analyses. A nomogram predicting LNI was developed and internally validated.Results and limitations
Overall, 62 patients (12.5%) had LNI. The median number of nodes removed was 15. The AUC for the Briganti 2012, Briganti 2017, and MSKCC nomograms was 82%, 82%, and 81%, respectively, and their calibration characteristics were suboptimal. A model including PSA, clinical stage and maximum diameter of the index lesion on multiparametric MRI (mpMRI), grade group on targeted biopsy, and the presence of clinically significant PCa on concomitant systematic biopsy had an AUC of 86% and represented the basis for a coefficient-based nomogram. This tool exhibited a higher AUC and higher net benefit compared to available models developed using standard biopsies. Using a cutoff of 7%, 244 ePLNDs (57%) would be spared and a lower number of LNIs would be missed compared to available nomograms (1.6% vs 4.6% vs 4.5% vs 4.2% for the new nomogram vs Briganti 2012 vs Briganti 2017 vs MSKCC).Conclusions
Available models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.Patient summary
We developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost of missing only 1.6% patients with LNI. 相似文献92.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
93.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
94.
95.
96.
97.
98.
Juliette A. Loncaster MD FRCR Ernest Allan 《Photodiagnosis and Photodynamic Therapy》2006,3(2):134-137
Gorlin syndrome (naevoid basal cell carcinoma syndrome) is a genetically linked disorder characterized by the development of multiple basal cell carcinomas (BCCs) throughout life. Cumulative surgery, cryotherapy and other conventional interventions can result in significant disfigurement by middle age. Radiotherapy is contra-indicated because the mutated gene underlying the syndrome, ‘PTCH’, increases sensitivity to ionising radiation, so there is significant likelihood of inducing further tumours in and around the irradiated area. Photodynamic therapy offers a non-invasive treatment option for patients with this condition, with the added advantage of causing minimal scarring. 相似文献
99.